Keywords: acambis, sells, berna, crucell, 5m, uk-based, vaccines

Acambis sells Berna to Crucell for $16.5M

Article | 09 October 2006

Print This

UK-based vaccines developer Acambis says that it has completed the sale of its Berna Products business to Dutch biotechnology firm ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in